Zelira Therapeutics is a globally recognized leader in cannabinoid-based medicine. With a focus on specific conditions, they are revolutionizing healthcare for millions of people who are underserved by current treatments. The brand brings deep pharmaceutical expertise to the development and commercialization of their proprietary cannabinoid-based medicines.

Zelira Therapeutics is committed to building patient and doctor confidence by utilizing an ethical, evidence-based approach. They apply world-class science and conduct clinical trials to ensure the effectiveness and safety of their medicines. As a leading biopharmaceutical company, Zelira Therapeutics has access to the world's largest and fastest-growing markets.

They offer a portfolio of proprietary revenue-generating products and have a pipeline of candidates undergoing clinical development, positioning them to enter global markets. In their Rx business, Zelira Therapeutics focuses on developing branded cannabinoid-based medicines for various medical conditions, including insomnia, autism, and chronic non-cancer pain. They also provide support to healthcare professionals and patients by offering cannabinoid-based medicines, ensuring alternative treatment options are accessible to those in need.

For more information, you can visit their website or contact Zelira Therapeutics directly